The current CEL market cap is 17.55M. The company's latest EPS is GBP -0.1078 and P/E is -2.46.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 0 | 0 | 0 | 24k | 149k |
Operating Income | -206k | -187k | -722k | -13.51M | -6.96M |
Net Income | -191k | -175k | -720k | -17.01M | -7.14M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 5.66M | 5.5M | 6.61M | 13.25M | 9.22M |
Total Liabilities | 33k | 42k | 197k | 6.21M | 6.04M |
Total Equity | 5.63M | 5.46M | 6.41M | 7.04M | 3.18M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -174k | -160k | -2.71M | -6.1M | -5.97M |
Investing | N/A | N/A | N/A | 1.39M | -341k |
Financing | 5.82M | N/A | 1.68M | 5.95M | 2.51M |
Market Cap | 17.55M |
Price to Earnings Ratio | -2.46 |
Price to Sales Ratio | 115.22 |
Price to Cash Ratio | 13.95 |
Price to Book Ratio | 5.52 |
Dividend Yield | - |
Shares Outstanding | 66.22M |
Average Volume (1 week) | 117.27k |
Average Volume (1 Month) | 63.97k |
52 Week Change | -67.88% |
52 Week High | 127.50 |
52 Week Low | 21.00 |
Spread (Intraday) | 1 (3.7%) |
Company Name | Celadon Pharmaceuticals Plc |
Address |
32-33 cowcross street london EC1M 6DF |
Website | https://celadonpharma.co.uk |
Industry | investment advice (6282) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.